International price comparison 2018 – an analysis of Swedish pharmaceutical prices and volumes relative to 19 other European countries
David Sjöberg, Andreas Ulden, Per Hortlund, Joakim Karlsson, and Niclas Stridsberg, amongst others (Tandvårds- och läkemedelsförmånsverket, TLV)
The Dental and Pharmaceutical Benefits Agency’s (TLV’s) mandate includes monitoring and analysing the price development of pharmaceuticals from an international perspective. In this report, TLV presents the results of the analysis of price and volume data for the first quarter of 2014, 2015, 2016, 2017 and 2018 in Sweden in comparison with 19 other European countries. The segments analysed are pharmaceuticals not exposed to competition and pharmaceuticals exposed to competition, with the latter including all pharmaceuticals available as substitutable medicines in the Swedish generic substitution system (product-of-the-month) as per March.
The report should be viewed as a basis for further analysis of the dynamics of Swedish prices and price changes compared to that seen internationally.
